Cargando…

Omega-3 fatty acids plus rosuvastatin improves endothelial function in South Asians with dyslipidemia

BACKGROUND: The present study was undertaken to investigate the effect of statins plus omega-3 polyunsaturated fatty acids (PUFAs) on endothelial function and lipid profile in South Asians with dyslipidemia and endothelial dysfunction, a population at high risk for premature coronary artery disease....

Descripción completa

Detalles Bibliográficos
Autores principales:	Mindrescu, Catalin, Gupta, Rakesh P, Hermance, Eileen V, DeVoe, Mary C, Soma, Vikas R, Coppola, John T, Staniloae, Cezar S
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2008
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663433/ https://www.ncbi.nlm.nih.gov/pubmed/19337557

Ejemplares similares

Histopathologic changes of the radial artery wall secondary to transradial catheterization
por: Staniloae, Cezar S, et al.
Publicado: (2009)

Efficacy and safety of rosuvastatin in the management of dyslipidemia
por: Rubba, Paolo, et al.
Publicado: (2009)

Effects of rosuvastatin combined with fasudil therapy on rabbits with dyslipidemia
por: Li, Zhiming, et al.
Publicado: (2015)

Combination Therapy of Ezetimibe and Rosuvastatin for Dyslipidemia: Current Insights
por: Chilbert, Maya R, et al.
Publicado: (2022)

Effects of Rosuvastatin Alone or in Combination with Omega-3 Fatty Acid on Adiponectin Levels and Cardiometabolic Profile
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2016)

Transradial approach to lower extremity interventions
por: Korabathina, Ravikiran, et al.
Publicado: (2010)

The efficacy and safety of co-administration of fimasartan and rosuvastatin to patients with hypertension and dyslipidemia
por: Rhee, Moo-Yong, et al.
Publicado: (2017)

Meta-analysis of the Efficacy and Safety of Adjunctive Rosuvastatin for Dyslipidemia in Patients with Schizophrenia
por: UNGVARI, Gabor S., et al.
Publicado: (2018)

Efficacy and safety of co‐administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia
por: Jin, Xuan, et al.
Publicado: (2020)

Obesity and Dyslipidemia in South Asians
por: Misra, Anoop, et al.
Publicado: (2013)

Cardiometabolic Risk Factors in Rosuvastatin-Treated Men with Mixed Dyslipidemia and Early-Onset Androgenic Alopecia
por: Krysiak, Robert, et al.
Publicado: (2021)

Objective-C
por: DeVoe, Jiva
Publicado: (2011)

Cocoa Touch for iPhone OS 3
por: DeVoe, Jiva
Publicado: (2009)

Antihypertensive effects of rosuvastatin in patients with hypertension and dyslipidemia: A systemic review and meta-analysis of randomized studies
por: Lee, Sungjae, et al.
Publicado: (2021)

Comparison of the Efficacy of Rosuvastatin 5 mg and 10 mg in Patients of Type 2 Diabetes Mellitus With Dyslipidemia
por: Aleem, Mudassar, et al.
Publicado: (2022)

Linear Superposition of Retinal Action Potentials to Predict Electrical Flicker Responses from the Eye of the Wolf Spider, Lycosa baltimoriana (Keyserling)
por: DeVoe, Robert D.
Publicado: (1962)

Linear Relations between Stimulus Amplitudes and Amplitudes of Retinal Action Potentials from the Eye of the Wolf Spider
por: DeVoe, Robert D.
Publicado: (1963)

Dual Sensitivities of Cells in Wolf Spider Eyes at Ultraviolet and Visible Wavelengths of Light
por: DeVoe, Robert D.
Publicado: (1972)

A Nonlinear Model for Transient Responses from Light-Adapted Wolf Spider Eyes
por: DeVoe, Robert D.
Publicado: (1967)

Nonlinear Transient Responses from Light-Adapted Wolf Spider Eyes to Changes in Background Illumination
por: DeVoe, Robert D.
Publicado: (1967)

Food Fishes and Their Diseases
por: DeVoe, Thomas F.
Publicado: (1880)

Efficacy and Safety of Coadministered Ezetimibe–Rosuvastatin plus Telmisartan in South Korean Patients with Dyslipidemia and Hypertension: A Multicenter, Randomized, Double-Blind, Active-Controlled, Phase III Trial
por: Song, Zhao-Yan, et al.
Publicado: (2023)

A comparative evaluation of safety and efficacy of rosuvastatin, simvastatin, and atorvastatin in patients of type 2 diabetes mellitus with dyslipidemia
por: Adsule, Samir Maruti, et al.
Publicado: (2009)

Real-World Effectiveness of Therapy With Rosuvastatin Combined With Fenofibric Acid in a Sample of Colombian Patients With Mixed Dyslipidemia
por: Machado-Duque, Manuel E., et al.
Publicado: (2020)

Aligning provider incentives to improve primary healthcare delivery in the United States
por: DeVoe, JE, et al.
Publicado: (2013)

Effect of rosuvastatin on fasting and postprandial endothelial biomarker levels and microvascular reactivity in patients with type 2 diabetes and dyslipidemia: a preliminary report
por: Kim, Kyoung Min, et al.
Publicado: (2017)

Effect of fixed‐dose combinations of ezetimibe plus rosuvastatin in patients with primary hypercholesterolemia: MRS‐ROZE (Multicenter Randomized Study of ROsuvastatin and eZEtimibe)
por: Kim, Kyung‐Jin, et al.
Publicado: (2016)

Time to consider an Asian guideline for management of dyslipidemia?
por: Yokote, Koutaro, et al.
Publicado: (2012)

Omega-3 carboxylic acids monotherapy and combination with statins in the management of dyslipidemia
por: Benes, Lane B, et al.
Publicado: (2016)

Omega 3 Fatty Acids vs Omega 6 Fatty Acids
por: Feliu, María, et al.
Publicado: (2022)

Adaptation in the Ventral Eye of Limulus is Functionally Independent of the Photochemical Cycle, Membrane Potential, and Membrane Resistance
por: Fein, A., et al.
Publicado: (1973)

Effect of Upadacitinib on the Pharmacokinetics of Rosuvastatin or Atorvastatin in Healthy Subjects
por: Mohamed, Mohamed‐Eslam F., et al.
Publicado: (2021)

Effects of rosuvastatin and/or β-carotene on non-alcoholic fatty liver in rats
por: Seif el-Din, Sayed H., et al.
Publicado: (2015)

Omega-minus plus 25 years
Publicado: (1989)

Retraction Note: Effect of rosuvastatin on fasting and postprandial endothelial biomarker levels and microvascular reactivity in patients with type 2 diabetes and dyslipidemia: a preliminary report
por: Kim, Kyoung Min, et al.
Publicado: (2019)

Comparison of Efficacy and Safety of Fixed Dose Combination of Rosuvastatin and Choline Fenofibrate to Fixed Dose Combination of Rosuvastatin and Fenofibrate in Patients of Mixed Dyslipidemia: A Randomized, Open-label, Multicentre Clinical Trial in Indian Population
por: Barkate, Hanmant, et al.
Publicado: (2018)

Association Between Omega‐3 Fatty Acid Intake and Dyslipidemia: A Continuous Dose–Response Meta‐Analysis of Randomized Controlled Trials
por: Wang, Tianjiao, et al.
Publicado: (2023)

Metastatic melanoma of the gallbladder presenting as polyp in acute cholecystitis
por: Saraswat, Nirvana B, et al.
Publicado: (2019)

Rosuvastatin reduces nonalcoholic fatty liver disease in patients with chronic hepatitis C treated with α-interferon and ribavirin: Rosuvastatin reduces NAFLD in HCV patients
por: Malaguarnera, Michele, et al.
Publicado: (2011)

Central blood pressure lowering effect of telmisartan‐rosuvastatin single‐pill combination in hypertensive patients combined with dyslipidemia: A pilot study
por: Choi, JungMin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cqjakc1tn47cmq6p77p445lo9n